Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound ; volume:20 ; number:4 ; day:4 ; month:6 ; year:2018 ; pages:1-8 ; date:7.2018
The AAPS journal / American Association of Pharmaceutical Scientists ; 20, Heft 4 (4.6.2018), 1-8, 7.2018
- Urheber
-
Goyal, Navin
- Beteiligte Personen und Organisationen
-
Mohamed, Khadeeja
Rolfe, Katie
Sahota, Satty
Ernest, Terry
Duparc, Stephan
Taylor, Maxine
Casillas, Linda
Koh, Gavin C. K. W.
SpringerLink (Online service)
- DOI
-
10.1208/s12248-018-0234-5
- URN
-
urn:nbn:de:101:1-2018091622485520033354
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goyal, Navin
- Mohamed, Khadeeja
- Rolfe, Katie
- Sahota, Satty
- Ernest, Terry
- Duparc, Stephan
- Taylor, Maxine
- Casillas, Linda
- Koh, Gavin C. K. W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Supporting and verifying transient behavior specifications in chaos engineering
Hall of half-life
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms
Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers
Halbwertszeit : [Protokolle des Zerfalls] = (Half-life)
The half-life of $$^212}$$ 212 Po
Dissolution
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release Tablets
Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements
Deriving object-oriented specifications from algebraic specifications through refinement
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Supporting and verifying transient behavior specifications in chaos engineering
Hall of half-life
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms
Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers
Halbwertszeit : [Protokolle des Zerfalls] = (Half-life)
The half-life of $$^212}$$ 212 Po
Dissolution
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release Tablets
Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements
Deriving object-oriented specifications from algebraic specifications through refinement
The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets
Supporting and verifying transient behavior specifications in chaos engineering
Hall of half-life
Developing clinically relevant dissolution specifications (CRDSs) for oral drug products: virtual webinar series
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms
Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers
Halbwertszeit : [Protokolle des Zerfalls] = (Half-life)
The half-life of $$^212}$$ 212 Po
Dissolution
Relationship Between Dissolution Rate in Vitro and Absorption Rate in Vivo of Ketamine Prolonged-Release Tablets
Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements